Pro
tocols should be in line with OECD Guideline 471 (Salmonella typhimuri
um Reverse Mutation Test), 472 (Escherichia coli Reverse
Mutation Test), 473 (in vitro Mammalian Chromosomal Aberration Test), 474 (Mammalian Erythrocyte Micronucleus Test), 475 (Mammalian Bone Marrow Chromosomal Aberration Test), 476 (in v
itro Mammalian Cell Gene Mutation Test) or 482 (Unscheduled
...[+++] DNA Synthesis in Mammalian Cells in vitro), as well as other relevant OECD Guidelines for in vitro and in vivo assays.De protocollen moeten
in overeenstemming zijn met OESO-richtsnoer 471 (Salmonella typhimuri
um Reverse Mutation Test), 472 (Escherichia coli Reverse
Mutation Test), 473 (in vitro Mammalian Chromosomal Aberration Test), 474 (Mammalian Erythrocyte Micronucleus Test), 475 (Mammalian Bone Marrow Chromosomal Aberration Test), 476 (in v
itro Mammalian Cell Gene Mutation Test) of 4 ...[+++]82 (Unscheduled DNA Synthesis in Mammalian Cells in vitro) en met andere relevante OESO-richtsnoeren voor in-vitro- en in-vivotests.